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Abstract
Background Allergenic pollen exposure is mostly seen
as an outdoor phenomenon but studies have shown
an indoor exposure: different pollen species including
birch and grass pollen in houses, schools, and shops
are leading to long-lasting symptoms even after the
pollen season because pollen settle on surfaces and
re-enter the indoor air depending on ventilation. To
reduce indoor pollen load, windows need to be closed
and devices should be used: as pure wiping and clean-
ing of surfaces is mostly not sufficient, air cleaners
may be helpful in reducing pollen counts in indoor
environment.
Objective The efficacy of an air cleaner is usually de-
scribed by the filtration rate of standard dust particle
sizes which is not necessarily related to clinical effi-
cacy.
Methods A novel study design was developed using
the technical equipment of a new mobile exposure
chamber to investigate participants with allergic rhini-
tis (individual observational, controlled, prospective,
single arm study).
Results The tested air cleaner reduced the grass
pollen-induced (4000 grass pollen/m3 over 90min)
nasal symptoms (total nasal symptom score) signifi-
cantly from 6 and 4 points (1st and 2nd exposure in
sham run) to less than 1 point when air cleaner was
activated.
Conclusions The novel study protocol is suitable
for testing efficacy of air cleaners and the tested air
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cleaner is effective in reducing clinical symptoms due
to grass pollen in an indoor environment.
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Abbreviations
FEV1 Forced expiratory volume in 1 s
PEF Peak expiratory flow
PNIF Peak nasal inspiratory flow
TNSS Total nasal symptom score
TSS Total symptom score
Introduction
Allergenic pollen are the most important and most
frequent trigger for allergic diseases [1]. In the Ger-
man adult population, pollen-induced allergies are
an enormous public health issue with a prevalence
of 14.8% physician-diagnosed hay-fever and 8.6%
asthma [2, 3]. Asthma and hay-fever lead to missed
school or working days, demand from families to
manage asthma care for their children, and increase
health care costs [4]. Since Europeans spend about
70% of their time at home, reducing exposures to
allergy and asthma triggers in residential settings is
an important goal in treating allergic patients.
Pollen exposure is mostly seen as an outdoor ex-
posure but studies have shown the presence of dif-
ferent pollen species including birch and grass pollen
in houses, schools, and shops [5–7] leading to long-
lasting symptoms even after the pollen season [8].
The objective of the study was to determine the ef-
ficacy of a readily available air purifier in removing air-
borne grass pollen with the aim of preventing nasal al-
lergy symptoms in persons with grass pollen-induced
allergic rhinoconjunctivitis. Grass pollen were chosen
















Fig. 1 Studydesign in themobile pollenchamber
due to the fact that they are globally present and have
a very high prevalence of sensitization [9].
Material and methods
Study design
In September 2015, a Philips AC4012 Air Purifier was
used in an individual observational (in-use observa-
tion), controlled, prospective, single arm study.
Exposure
The air cleaner efficacy was investigated in a mo-
bile exposure chamber (www.mcxperts.com), which is
technically designed to ensure standardized allergen
exposure of each individual participant [10]. It has un-
dergone a comprehensive clinical evaluation for expo-
sures to grass and birch pollen [11]. Tests were done
in three steps.
1. Testing the potential influence of the active air pu-
rifier (and its airflow at the outlet) on triggering
symptoms.
The participants sat in the pollen chamber at a dis-
tance of 150 cm from the outlet of the air purifier,
which was equipped with a filter. No pollen was re-
leased. The participants were solely exposed to inside
air and airflow from the air purifier. This distance was
maintained for all further tests with pollen and the
outlet of the air purifier with and without the filter.
2. Pollen exposure without filter in the air purifier
(sham run): participants were exposed twice on
two different days to a concentration of 4000
grass pollen/m3 air per 90-minute observation
period. Comparative measurements proved that
the selected concentration triggers a score of about
6 points on the symptom severity scale. The grass
pollen were released through the air purifier device
without the filter cartridge in place (Fig. 1).
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Fig. 2 Overviewof theTo-
tal SymptomScore (TSS,
meanvalues) before andaf-
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Airflow – TSS means 
To connect the pollen outlet in the chamber’s ceiling
to the inlet of the air purifier, it was placed under
the pollen outlet with the air inlet facing the pollen
outlet. Due to the suction of the machine, no other
connection was needed to direct the full amount of
pollen through the air purifier. The functioning of the
setup was measured with a laser particle counter. The
air outlet was directed in a horizontal position towards
the participants. During exposure, two participants
were in the pollen chamber.
3. Pollen exposure with filter in the air purifier: partic-
ipants were exposed twice on two different days to
a concentration of 4000 grass pollen/m3 air per 90-
minute observation period. The grass pollen were
released through the air purifier device with the fil-
ter cartridge in place.
Test parameter and symptom severity
The following parameters were recorded before, dur-
ing, and after the exposure:
● Symptoms of the eyes, nose, and bronchia every
10min.
● Peak nasal inspiratory flow (PNIF) every 30min.
● Spirometry (FEV1, forced expiratory volume in 1 s)
and peak expiratory flow (PEF) before and after ex-
posure.
The total symptom score (TSS) was compiled by eval-
uating the following symptoms:
● Eyes: itching, irritation, redness, tearing.
● Nose: itching, sneezing, runny nose, congestion.
● Bronchial: wheezing, coughing, shortness of breath,
asthma.
All symptoms were scored as: no symptoms = 0, mild =
1, moderate = 2, severe = 3. The TSS scale allows
a maximal symptom score of 12 points per organ.
Since nasal symptoms account for over 80% of total
symptoms, the total nasal symptom score (TNSS) is
a critical parameter for determining the results of in-
tervention in allergic rhinitis.
Participants
Four non-smoking participants (male = 3, female = 1;
age = 25–29 years) were asked for their written and
oral consent in an in-depth discussion with the study
doctor who provided information on study participa-
tion and data storage. The inclusion criteria were age
>18 years with a diagnosis of allergic rhinitis and/or
conjunctivitis for at least two years during the months
of the respective pollen season and a positive skin
prick test with grass pollen allergen (>3mm). They
had no completed or currently immunotherapy within
the last five years and no treatment with an antihis-
tamine during the last week before challenge. The
study based on a positive vote from the ethics com-
mission of Charité, Universitätsmedizin Berlin, Ger-
many.
Results
Preliminary tests During the 30-minute exposure
period with the active air purifier but without pollen
in the chamber, practically no symptoms occurred
(Fig. 2). There was a very mild bronchial irritation
less than 1 point (0.75 points) at the baseline value,
which lessened after 10 to 30min. Only minimal
symptoms were documented after 30min in the eyes
and after 10 and 30min in the nose.
Exposure tests with grass pollen with air purifier in
sham mode During the 90-minute exposure with
a concentration of 4000 grass pollen/m3, allergic
symptoms occurred on the nose, and to a lesser
degree on eyes and bronchi. In the first run the
probands reached a plateau in the TSS after 60min
above 6 points. In the second run they reached
4 points after 60min and had no further increase
K A novel experimental technology for testing efficacy of air purifiers on pollen reduction 3
original article
Fig. 3 Progressionof the
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Fig. 4 Progressionof
the total nasal symptom
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(Fig. 3). The TNSS showed a similar development
(Fig. 4).
Exposure tests with grass pollen with active air pu-
rifier During the 90-minute exposure with iden-
tical pollen concentration and test conditions the
probands developed nearly no symptoms on nose,
eye, and bronchi. Both, TSS and TNSS remained
under 1 point – similar as during the exposure of
the pollen-free air outlet from the air purifier (Figs. 3
and 4).
Discussion
Pollen allergy is the most frequent allergic disease in
the world. In Germany, at least 14.8% of adults [2] and
10.7% of children and adolescents [12] are suffering
from allergic rhinoconjunctivitis due to pollen.
The natural exposure to pollen is typically an out-
door exposure. The rational of our study on the
efficacy of an air cleaner are reports on pollen in
homes, too. Yli-Panula & Rantio-Lehtimäki reported
on birch pollen allergens in indoor settled dust which
was lower than outdoors dust [5]. The mean con-
centration of allergenic activity indoors peaked three
weeks later than outdoors and the birch allergenic
activity was still detected two months after the birch
peak pollen period. Also, cedar pollen allergen (Cry j I)
was still found in house dust collected two weeks after
airborne C. japonica pollen had disappeared outside
[13]. Therefore, indoor dust may be an important
cause of birch pollen-induced symptoms after the
season.
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Fahlbusch and colleagues reported on consider-
able high level of grass pollen allergens in indoor
dust even during periods when no grass pollen was
present in the atmosphere suggesting that indoor
pollen may be an important cause of pollen-allergy
symptoms outside of season [6]. They measured the
major grass pollen allergen in samples from five ran-
domly selected homes in Germany. Dust samples
were collected from floor of living rooms, bedrooms,
children’s rooms, and mattresses during the period of
June 1995 to August 1998. Phl p 5 was detected in
67% of the samples analyzed (n = 4760) with a range
between undetectable (<0.03 μg/g dust and 81 μg/g
dust). The levels were significantly higher in the dust
from living rooms (geometric mean 0.117μg/g dust)
or bed room floors (geometric mean 0.098 μg/g dust)
than in mattresses (geometric mean 0.043 μg/g dust).
Phl p 5 content indoors also reflected the different
quantities of pollen counts of annual courses. Dur-
ing pollination period, the concentrations were two
times higher than out of grass pollination season [8].
Quantification of birch and grass pollens and their
allergens in indoor air of two school and two office
rooms showed that the indoor air carried substantial
amounts of pollen allergens [7]. Parietaria judaica al-
lergenic activity was measured in Italy in the dust of
roomswith the balcony open on some days and closed
on others [14]. Statistical analysis indicated a signifi-
cant correlation between outdoor allergen levels and
indoor allergen levels with balcony open but not with
balcony closed.
It was shown that frequent cleaning (vacuuming of
carpets) reduces the indoor exposure to grass pollen
allergens [8] but modern technology of air cleaners
may offer an easier way of avoiding exposure to pollen
for hay-fever sufferers in their homes.
There are few published data on the efficacy of
air cleaners in reducing pollen counts or pollen aller-
gen concentrations in indoor air or indoor dusts. In
one study, the effect of electrostatic air cleaning (in-
door air samples) on birch and grass pollen was stud-
ied under authentic working conditions in May and
July 1999 in two street-level shops [15]. The average
concentration of airborne indoor birch pollen aller-
gen in the shop with air cleaning was estimated to be
20 ± 9 SQ/m3 (mean ± SD) compared to 31 ± 17 SQ/m3
(mean ± SD) of that without. The air cleaner reduced
the indoor air birch pollen allergen concentration by
on average 26 to 48% (p < 0.05). Corresponding figures
for airborne indoor grass pollen allergen concentra-
tions were 14 ± 7 SQ/m3and 17 ± 8 SQ/m3, indicating
a statistically non-significant (t-test) average 18% re-
duction of allergens by air cleaning. In another study,
electrostatic air cleaning in an office room reduced
its grass pollen allergen concentrations by more than
95% as compared to the control room [7].
In our study, we first documented that the airflow
from the air cleaner itself is not irritating the nose
or eye of the users; there were no clinically relevant
symptoms on both organs. This result may have clini-
cal importance – the air cleaner can stay near to a bed
or chair and is not inducing any harm itself because
of his air flow.
The new developed technology of very standard-
ized pollen exposures in specifically designed cham-
bers allows measuring the efficacy of an air cleaner in
detail, comparing the same concentration of pollen in
the ambient air with and without the cleaner. Using
a validated concentration of 4000 grass pollen/m3 air,
four patients with allergic rhinitis due to grass pollen
developed a total symptom score of about 6 points.
This severity of nasal symptoms is similar to nasal
symptom severity reported in Germany by the users
of an electronic patient diary on allergy symptoms in
a pollen App [16] during grass pollen season.
In the study, the pollen influx was directed to the air
purifier, in real life condition the device would take the
airborne pollen from the room but the efficacy should
be in the same range. The number of probands is
small because of limits in financial resources.
Grass pollen were chosen for provocation due to the
fact that they have a globally broad geographical ex-
tension and a very high prevalence of sensitization [9].
Pollen concentrations are lower outside than we used
in the chamber but urban air pollution may affects
airborne allergenic pollen [17] and therefore induces
more severe allergic reactions even with a much lower
amount of pollen in the air as is it was used in cham-
ber studies. Also, the influence of a smaller micronic
atmospheric aerosol fraction outside the chamber [18]
may influence the relation between pollen counts and
symptoms.
Under identical and repeated exposure conditions
over 90 min, the air cleaner significantly inhibited the
symptoms of the probands under a severity level of 1;
that means that they had no more allergic symptoms
on eyes, nose, or bronchi. The results show that the
pollen concentration was effectively influenced by the
air cleaner.
Conclusions
The presence of the tested air purifier in active use
(i. e., used as intended) did not result in any irritations
of nose, eyes, or bronchia in unmedicated persons
with allergic rhinitis due to grass pollen.
The exposure in an exposure chamber to 4000 grass
pollen/m3 over a 90-minute period under standard-
ized conditions led to the development of nasal symp-
toms on a scale of up to 6 points as in real life condi-
tions.
The presence of the tested air purifier, used as in-
tended, resulted in the complete prevention of symp-
toms in the nose, eyes, and bronchia in the tested
pollen allergy sufferers. The level of symptom severity
was less than 1 point in both the total symptom score
and the total nasal symptom score.
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